Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
January 15, 2019, I was diagnosed with Chronic Lymphocytic Leukemia (CLL). This life-altering experience ignited a passion for holistic well-being. I believe true transformation happens on three levels: physical, mental, and spiritual. Discover how accountability and strong relationships can dramatically increase your chances of achieving your goals. Join me on a journey of Grit, Grace and Transformation as we explore the power of whole-person health. What change are you ready to embrace?
…
continue reading
This is a mostly upbeat, sometimes downbeat, look at my life with Chronic Lymphocytic Leukemia a.k.a, CLL. Though CLL could also stand for "Could'a Lived Longer," I believe you can still have a life well-lived despite your CLL. I hope hearing about my journey will encourage you on your walk with leukemia.
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Healthcare Unfiltered is an honest, raw, timely podcast tackling any and all topics in healthcare that affect stakeholders. Dr. Chadi Nabhan uses his dynamic conversational skills to challenge his guests to address controversial and important topics. He also brings on world renowned experts to discuss clinical advances in medicine.
…
continue reading
For the first Canadian Lacrosse League (CLL) Podcast, RUGBURN, League Founder and Canada General Manager, Chris Fox, talks with some of the best 16 to 21 year old box lacrosse players in the world - giving fans access to junior lacrosse like never before. Players will share their stories as elite athletes navigating a balance between life and lacrosse, all in the pursuit of playing professionally in the National Lacrosse League (NLL).
…
continue reading
Podcast by Managed Care Cast
…
continue reading
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth. Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, video capsules, and podcasts at: https://www.impactmedicom.com.
…
continue reading
Join us for the Unraveling Cancer Podcast Series where we explore stories and news about living with cancer, the latest research from conferences, and patient advocate stories. Our patient hosts are joined by leaders in the field; from researchers working on the treatments of tomorrow, to holistic practitioners and mental health professionals. Patient Power® is a leader in supporting patients with cancer and caregivers in their treatment journey; interviewing top medical experts and research ...
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
Welcome to Basics to Brilliance, the Haematology podcast created to supplement & bolster your knowledge for the FRCPath Part 1. Featuring a two way, non-didactic conversational-style Q&A between the SpR and SHO, this podcast will be your pocket companion no matter where you are. We aim to cover: - Malignant and non-malignant topics - The whole syllabus for FRCPath part 1 - Review UK guidelines - Go into science/lab detail - Discuss how guidelines often translate into practice - Review and ap ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mosunetuzumab in relapsed/refractory follicular lymphoma, CD70 CAR T-cells and an anti-CD33/anti-CD3 bispecific antibody in acute myeloid leukemia, and ferroptosis in stored red blood cells
23:14
23:14
Play later
Play later
Lists
Like
Liked
23:14In this week's episode we’ll find out about longer term results from a pivotal trial of mosunetuzumab in relapsed/refractory follicular lymphoma, potential use of CD70 CAR T-cells that secrete an anti-CD33/anti-CD3 bispecific antibody as a therapy for acute myeloid leukemia, and how ferroptosis regulates hemolysis in stored red blood cells. Feature…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Review Series on Basic/Translational Science of Factor VIII, Factor IX, and von Willebrand Factor
31:38
31:38
Play later
Play later
Lists
Like
Liked
31:38In this Review Series episode on Basic/Translational Science of Factor VIII, Factor IX, and von Willebrand Factor introduced by Dr. Thomas Ortel, we’ll hear from contributing authors Drs. Ben Samuelson Jones, Mac Monroe and Peter Lenting as they discuss how the functional roles of these 3 proteins are interconnected. Click here to view the complete…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 56. Management of Newly Diagnosed CML with Dr. Hagop Kantarjian
1:02:55
1:02:55
Play later
Play later
Lists
Like
Liked
1:02:55In this episode, we discuss the management of CML with Dr. Hagop Kantarjian from MD Anderson Cancer Center. Here are the key articles we discussed: 1. ASC4FIRST RCT: Asciminib in newly diagnosed CML. https://pubmed.ncbi.nlm.nih.gov/38820078/ 2. 5-year follow-up of ENESTnd RCT (nilotinib): https://pubmed.ncbi.nlm.nih.gov/26837842/ 3. 10-year follow-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Joyce O'Shaughnessy, MD - Targeting PIK3CA/AKT1/PTEN and Other Alterations in HR+, HER2- MBC: Navigating the Evidence and Guidance for Use
1:01:51
1:01:51
Play later
Play later
Lists
Like
Liked
1:01:51This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Joyce O'Shaughnessy, MD - Targeting PIK3CA/AKT1/PTEN and Other Alterations in HR+, HER2- MBC: Navigating the Evidence and Guidance for Use
1:01:51
1:01:51
Play later
Play later
Lists
Like
Liked
1:01:51This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Joyce O'Shaughnessy, MD - Targeting PIK3CA/AKT1/PTEN and Other Alterations in HR+, HER2- MBC: Navigating the Evidence and Guidance for Use
1:01:51
1:01:51
Play later
Play later
Lists
Like
Liked
1:01:51This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Telemedicine’s Evolution: Expanding Access to Obesity and Specialty Care
24:32
24:32
Play later
Play later
Lists
Like
Liked
24:32On this episode of Managed Care Cast, we speak with George Jones, chief operating officer at UpScript Health, an online pioneer of eprescribing 20 years ago, to learn how telemedicine has progressed from asynchronous conferencing to real-time video consultation, enabling the treatment of complex conditions beyond primary care.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Lucia M. Novak, MSN, ANP-BC, BC-ADM - Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity
33:07
33:07
Play later
Play later
Lists
Like
Liked
33:07This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/N…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting
20:01
20:01
Play later
Play later
Lists
Like
Liked
20:01In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently presented at the 2024 annual American Society of Hematology meeting, including: Early results with teclistamab combined with anti-CD38 therapy Real-world data with teclistamab including its use aft…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Highlander Health: Data-Driven Innovation in Medicine
41:15
41:15
Play later
Play later
Lists
Like
Liked
41:15Amy Abernethy and Brad Hirsch, co-founders of Highlander Health, delve into their mission to transform healthcare through innovative, data-driven strategies. They discuss their firm's unique approach to investing in companies and technologies that advance personalized care, the creation of the Evidence Accelerator to streamline high-quality real-wo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dual TKI targeting in Ph+ ALL; role of liver endothelial ferroportin in iron sensing and homeostasis; severe anemia in pregnant patients with beta-thalassemia minor
18:41
18:41
Play later
Play later
Lists
Like
Liked
18:41In this week's episode we'll learn about asciminib plus dasatinib in Philadelphia chromosome-positive acute leukemia. In a phase 1 study, combining two tyrosine kinase inhibitors with distinct mechanisms of action had encouraging activity in patients with de novo disease. After that: new research demonstrates that the iron exporter ferroportin cont…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025
18:29
18:29
Play later
Play later
Lists
Like
Liked
18:29This podcast brings you exclusive updates on multiple myeloma from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held in San Diego, CA. In this episode, experts Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Cen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Prof. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact
1:01:04
1:01:04
Play later
Play later
Lists
Like
Liked
1:01:04This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAP…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Prof. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact
1:01:04
1:01:04
Play later
Play later
Lists
Like
Liked
1:01:04This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAP…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Prof. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact
1:01:04
1:01:04
Play later
Play later
Lists
Like
Liked
1:01:04This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAP…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches
47:14
47:14
Play later
Play later
Lists
Like
Liked
47:14This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches
47:14
47:14
Play later
Play later
Lists
Like
Liked
47:14This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches
47:14
47:14
Play later
Play later
Lists
Like
Liked
47:14This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Politics vs Science: The Future of US Public Health
28:15
28:15
Play later
Play later
Lists
Like
Liked
28:15On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health. Our conversation centers on the potential withdrawal of the United States from the World Health Organization, the new directive for the CDC to stop communications with the WHO, and their public health implications. We al…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
VersaWare: The Story of a Diet Startup Company
38:53
38:53
Play later
Play later
Lists
Like
Liked
38:53Chadi sits down with Creed McKinnon, Co-Founder and Chief Growth Officer of VersaWare, to explore how this cutting-edge startup is redefining the intersection of technology and nutrition. VersaWare’s AI-powered platform integrates voice assistants and real-time chatbot support from expert nutritionists to simplify meal building, enhance recipe disc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Professor Melanie Davies - Understanding the Individual in Front of You: The Importance of Patient Participation in Weight and Glycaemic Management for People With Type 2 Diabetes
35:36
35:36
Play later
Play later
Lists
Like
Liked
35:36This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EYG865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML
28:59
28:59
Play later
Play later
Lists
Like
Liked
28:59In this podcast, we bring you exclusive updates on acute myeloid leukemia (AML) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. You will hear insights into novel approaches to frontline chemotherapy and BCL2 inhibition from experts Ioannis Mantzaris, MD, Montefiore Medical Center/…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia
20:37
20:37
Play later
Play later
Lists
Like
Liked
20:37In this week's episode we’ll learn more about a phase 2 trial of first-line zanubrutinib, obinutuzumab, and venetoclax in TP53-mutated mantle cell lymphoma; early development of hyperdiploidy in multiple myeloma; and a phase 1 trial of the asparaginase pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia. Featured Articles…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Vera Bril, BSc, FRCPC, MD - Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
33:12
33:12
Play later
Play later
Lists
Like
Liked
33:12This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Amy J. McMichael, MD - From Roots to Results: Elevating Alopecia Areata Management
39:24
39:24
Play later
Play later
Lists
Like
Liked
39:24This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/QXZ865. …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more!
22:21
22:21
Play later
Play later
Lists
Like
Liked
22:21This podcast episode covers key highlights in myeloproliferative neoplasms (MPNs) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear key trial updates in myelofibrosis (MF) from Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL, Lucia Masarova, MD, The Univ…
…
continue reading
Today, we're diving deep into a crucial aspect of preventive healthcare: the Annual Wellness Visit. Our guest is Dr. Christopher Wheelock, a clinical transformation physician executive at Highmark Health, responsible for developing payer and provider collaborations to move toward value-based care. In the past, he was heavily involved with developin…
…
continue reading
Dr. Andrew Foy, a cardiologist at Penn State Health, returns to the show to unpack the findings of his JAMA publication exploring industry payments in medicine and their influence on clinical practice. He examines how financial relationships with the industry may shape guideline recommendations, alter quality-of-care metrics, and contribute to pote…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Post-ASH NHL highlights: novel combinations in the frontline setting and advancements with immunotherapy in the R/R setting
31:20
31:20
Play later
Play later
Lists
Like
Liked
31:20Today's podcast showcases key updates in non-Hodgkin lymphoma (NHL) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear from Gilles Salles, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, Catherine Diefenbach, MD, NYU Langone, New York, NY, and Jia …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
15:00
15:00
Play later
Play later
Lists
Like
Liked
15:00On this episode of Managed Care Cast, we're talking with Allison Ju-Chen Hu, PhD, a postdoctoral associate in the Department of Population Health Sciences at Weill Cornell Medicine.Her study, "Medicaid Managed Care Network Adequacy Standards and Mental Health Care Access," examined the association between quantitative network adequacy standards (NA…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Targeting C3 in autoimmune hemolytic anemias; venetoclax testing to predict AML response; an improved understanding of the structure of FXIII complex
19:02
19:02
Play later
Play later
Lists
Like
Liked
19:02In this week's episode we'll learn about C3-targeted therapy in autoimmune hemolytic anemias. Based on results of an open-label, phase 2 study, pegcetacoplan was well-tolerated, with encouraging efficacy, particularly in patients with cold agglutinin disease. After that: Venetoclax sensitivity testing to predict AML response. In a significant step …
…
continue reading
In this Review Series episode on Globin Disorders introduced by Drs. Thomas Coates and Irene Roberts, we’ll hear from Dr. Douglas Higgs and Dr. Mitchell Weiss as they address advances in our understanding of globin gene biology. Click here to view the complete Review Series featured in Volume 144 Issue 8 of Blood.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Kristina M. Deligiannidis, MD - The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment
44:05
44:05
Play later
Play later
Lists
Like
Liked
44:05This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/NCN865. CME/MOC/AAPA c…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Michelle Kittleson, MD, PhD / Senthil Selvaraj, MD, MS, MA - Don’t Fail Them Now: Bridging Diagnostic and Treatment Gaps in Transthyretin Cardiac Amyloidosis
59:21
59:21
Play later
Play later
Lists
Like
Liked
59:21This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/QTM865. CME/NC…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Milind Desai, MD, MBA, FACC, FAHA, FESC - Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM and Beyond
1:01:53
1:01:53
Play later
Play later
Lists
Like
Liked
1:01:53This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MO…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bird Flu Risks, Myths, and Prevention Strategies: A Conversation With the NFID’s Robert Hopkins, MD
16:29
16:29
Play later
Play later
Lists
Like
Liked
16:29Joining us for this episode of Managed Care Cast is Robert H. Hopkins, Jr, MD, mnedical director at the National Foundation for Infectious Diseases and NFID liaison to the Advisory Committee on Immunization Practices, who will help separate fact from fiction about avian influenza and discuss what needs to be done to prevent a future escalation.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Myths and Facts of Early Lung Cancer Detection
54:19
54:19
Play later
Play later
Lists
Like
Liked
54:19Dr. Lecia Sequist, an expert in lung cancer and early detection, and Dr. Jeff Yang, a renowned thoracic surgeon, join Chadi to unravel the complexities of early lung cancer detection. Together, they explore the nuances of lung cancer screening, including the challenges of overdiagnosis and managing false-negative and false-positive results. The dis…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS
19:02
19:02
Play later
Play later
Lists
Like
Liked
19:02This podcast is the second episode in our series spotlighting key highlights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. This episode focuses on updates in myelodysplastic syndromes (MDS). You will hear insights into managing anemia in lower-risk MDS (LR-MDS) from Sophie Park,…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Brentuximab vedotin, nivolumab, and chemotherapy in classical Hodgkin lymphoma; type 1 interferon signaling in sickle cell disease; and type 1 human leukocyte antigen gene mutations in cutaneous T-cell ...
21:35
21:35
Play later
Play later
Lists
Like
Liked
21:35In this week's episode we’ll learn more about an experimental regimen for classical Hodgkin lymphoma that combines brentuximab vedotin, nivolumab, and chemotherapy; a possible role for type 1 interferon signaling in developing autoantibodies to red blood cells in sickle cell disease; and how genomic alterations affecting class I human leukocyte ant…
…
continue reading
A special from our one of our partners.By Patient Power
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Caring for the Caregiver With Maz Jobrani
45:57
45:57
Play later
Play later
Lists
Like
Liked
45:57Maz Jobrani, star standup comedian and actor, joins the show to share his career journey and his beginning as an immigrant turned comedian and celebrity. Maz shares his sister's journey when diagnosed with breast cancer at a very young age. He opens up with details on challenges of being one of her caregivers and how he balanced comedy with tragedy…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 55. ASH 2024 Myeloma Updates with Dr. Rakesh Popat
38:26
38:26
Play later
Play later
Lists
Like
Liked
38:26In this episode, we dive into the hottest updates in myeloma and amyloidosis at ASH 2024 annual meeting with Dr. Rakesh Popat. Here are the abstracts we discussed: 1. AQUILA Trial in High-Risk SMM Overview of the AQUILA trial testing single-agent daratumumab for high-risk smoldering multiple myeloma (HR-SMM) versus active monitoring. Discussion on …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more!
16:31
16:31
Play later
Play later
Lists
Like
Liked
16:31VJHemOnc recently attended the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, where we gained expert insights into cutting-edge research in hematological malignancies. This podcast series will cover highlights in a variety of disease areas. Today's episode focuses on chronic lymphocytic leukemia (CLL). You…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy
21:53
21:53
Play later
Play later
Lists
Like
Liked
21:53Today, we do a deep dive into psychedelic-assisted therapy with Jessica Tracy, head of Growth and Partnerships at Enthea. She shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.By Managed Care Cast
…
continue reading
![Artwork](/static/images/128pixel.png)
1
"It is Not the Mountain We Conquer, but Ourselves." ~ Sir Edmund Hillary
17:52
17:52
Play later
Play later
Lists
Like
Liked
17:52Send us a text https://ggtlife.com/ Hello Hello Y’all! It is here! Welcome to Season 5 of the Grit Grace and Transformation Podcast. We'll be scaling the peaks of well-being together, one informative conversation at a time. Get ready to discover practical tools you can use right away, like setting up base camp with the latest trends in food and nut…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Iron overload aggravates MDS pathophysiology; long-term outcomes after TPO-RA treatment in ITP; new insights into APL treatment outcomes by age and risk
17:20
17:20
Play later
Play later
Lists
Like
Liked
17:20In this week's episode we'll learn about the role of iron in myelodysplastic syndromes, or MDS. After that: long-term treatment outcomes in immune thrombocytopenia from the STOPAGO study. Finally, new insights into APL treatment outcomes and prognostic factors from the large-scale Harmony APL project which used ATRA-Arsenic combination therapy. Fea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer
36:04
36:04
Play later
Play later
Lists
Like
Liked
36:04In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways from a live symposium, including from key abstracts presented at the 2024 San Antonio Breast Cancer Symposium: Estrogen receptor mutations in patients With HR-positive/HER2-negative advanced breast ca…
…
continue reading